Source: Annual Congress 2005 - Therapy in allergic airway disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Rak, A. Stender, R. Dahl (Gothenburg, Sweden; Hørsholm, Aarhus, Denmark). Confirmed clinical safety and efficacy of grass allergen tablets. Eur Respir J 2005; 26: Suppl. 49, 905

Member's Comments

No comment yet.

Related content which might interest you: Efficacy and safety of 300IR 5-grass pollen sublingual tablet in allergic patients with and without asthma Source: Annual Congress 2012 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2012 Evaluation of acceptability, efficacy and safety of a novel dry powder inhaler in patients with persistent asthma Source: Eur Respir J 2007; 30: Suppl. 51, 70s Year: 2007 Specific immunotherapy with high dose grass allergen tablets was safe in grass pollen induced asthma Source: Eur Respir J 2005; 26: Suppl. 49, 134s Year: 2005 Evaluation and efficacy of allergen immunotherapy in asthma Source: Eur Respir J 2005; 26: Suppl. 49, 399s Year: 2005 Contamination and carry-over in clinical pharmacokinetic trials with aerosolized budesonide Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I Year: 2011 A post-marketing study to evaluate the safety and tolerability of a non-chlorofluorocarbon salbutamol inhaler in asthmatic patients in general practice Source: Eur Respir J 2002; 20: Suppl. 38, 78s Year: 2002 Evaluation of the immunogenicity and safety of a new formulation of omalizumab (solution for injection) in patients with allergic (IgE-mediated) asthma Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009 Efficacy and safety of omalizumab in real-life practice in India Source: Annual Congress 2012 - Asthma: risk factors and effect of anti-IgE Year: 2012 Efficacy and safety of levocetirizine in persistent allergic rhinitis (PER) Source: Eur Respir J 2005; 26: Suppl. 49, 136s Year: 2005 RCT to evaluate the efficacy and safety of ivy leaves cough liquid Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action Year: 2016 Safety of formoterol in asthma clinical trials Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012 Clinical efficacy of new non-freon aerosol troventol in asthma patients Source: Annual Congress 2006 - Recent advances in asthma treatment Year: 2006 Efficacy and safety of fluticasone/formoterol compared to fluticasone alone in patients with asthma Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD Year: 2012 Safety of 5-grass pollen extract sublingual tablet in patients with grass pollen-induced allergic rhinoconjunctivitis and concomitant intermittent asthma: A pooled analysis Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Long-term safety and efficacy of budesonide/formoterol in Japanese patients with asthma Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases II Year: 2008 Efficacy and safety profile of doxofylline compared to theophylline in asthma: a meta-analysis Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts Year: 2019 The efficacy and safety of fluticasone propionate on Chinese asthmatics Source: Eur Respir J 2001; 18: Suppl. 33, 97s Year: 2001 Effects of oromucosal immunotherapy (SLIT) in children with respiratory allergy Source: Eur Respir J 2002; 20: Suppl. 38, 525s Year: 2002 Long-term treatment of aspirin-intolerante asthma with budesonide. Effectivity and safety Source: Eur Respir J 2001; 18: Suppl. 33, 156s Year: 2001 Comparative efficacy and safety of mometasone furoate dry powder inhaler and budesonide Turbuhaler(R) Source: Eur Respir J 2001; 17: 1332-1333 Year: 2001